P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
6,068.00
-396.5 (-6.13%)
BSENSE

Aug 06, 03:30 PM

BSE+NSE Vol: 1.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,037.52
712.65
324.87
45.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,037.52
712.65
324.87
45.59%
Raw Material Cost
222.14
295.24
-73.10
-24.76%
Purchase of Finished goods
48.27
0.00
48.27
(Increase) / Decrease In Stocks
1.80
38.37
-36.57
-95.31%
Employee Cost
171.70
55.05
116.65
211.90%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
272.54
101.17
171.37
169.39%
Total Expenditure (Excl Depreciation)
716.45
489.83
226.62
46.27%
Operating Profit (PBDIT) excl Other Income
321.07
222.82
98.25
44.09%
Other Income
13.34
45.74
-32.40
-70.84%
Operating Profit (PBDIT)
334.41
268.56
65.85
24.52%
Interest
0.34
5.66
-5.32
-93.99%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
334.07
262.90
71.17
27.07%
Depreciation
17.42
17.54
-0.12
-0.68%
Profit Before Tax
316.65
245.37
71.28
29.05%
Tax
84.34
61.89
22.45
36.27%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
232.31
183.48
48.83
26.61%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
232.31
183.48
48.83
26.61%
Equity Capital
16.60
34.69
-18.09
-52.15%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
30.95%
31.27%
0.00
-0.32%
Gross Profit Margin
32.20%
36.89%
0.00
-4.69%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,037.52 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 232.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 321.07 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

Nine Monthly - Interest
Interest 0.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024